Literature DB >> 10334040

Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion.

J Rajcáni1, M Kúdelová.   

Abstract

Glycoprotein K (gK) encoded by the UL53 gene is the ninth out of eleven HSV glycoproteins (gps). The precursor gK (pgK) is a transmembrane protein with four hydrophobic domains, which consists of 338 amino acids. The UL53 gene has two initiation codons: the upper overlaps with the UL52 ORF, while the lower is located 55 codons downstream and specifies a truncated precursor of the gK polypeptide. The UL53 gene and the upstream located UL52 gene have a common polyadenylation signal downstream from the UL53 stop codon so that the UL53 mRNA is completely nested within the UL52 transcript. The syn1 mutations in several KOSsyn mutants and in the MPsyn virus, which had been fine mapped to DNA coordinates 0.735-0.740, were later on located to the UL53 gene, especially to its portion which specifies the first 120 amino acids (aa) from the N-terminus (most frequently residue 40) and to a less precisely defined locus between aa 301-310 (close to the C-terminus). Point mutations in the N-terminal ectodomain of gK, which are related to syn formation, impair the putative ability of this region to down-regulate membrane fusion. The two N-glycosylated mannose core oligosaccharides are attached to the Asn residues of the gK polypeptide at positions 48 and 58, respectively. In infected cells, gK is localized mainly in the nuclear and endoplasmic reticulum (ER) membranes. It is not clear, whether gK becomes incorporated into the envelope of mature HSV particles. Studies with the insertion/deletion gK mutants showed the importance of gK for capsid envelopment, for the transportation and egress or virions from infected cells. It seems that gK has an essential role in virion egress, even though this glycoprotein acts in accord with gH and with another membrane protein encoded by the UL20 gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334040     DOI: 10.1023/a:1008025520655

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  55 in total

1.  Phenotypic and genotypic characterization of locus Syn 5 in herpes simplex virus 1.

Authors:  M Tognon; R Guandalini; M G Romanelli; R Manservigi; B Trevisani
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

2.  Syn strains HSZP and ANGpath [correction of ANG] of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation.

Authors:  M Kúdelová; A Vojvodová; J Rajcáni
Journal:  Acta Virol       Date:  1998-02       Impact factor: 1.162

3.  The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP.

Authors:  K L Pogue-Geile; P G Spear
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

4.  Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity.

Authors:  P J Desai; P A Schaffer; A C Minson
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

5.  Syncytial mutations in the herpes simplex virus type 1 gK (UL53) gene occur in two distinct domains.

Authors:  K E Dolter; R Ramaswamy; T C Holland
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  The isolation and characterization of mutants of herpes simplex virus type 1 that induce cell fusion.

Authors:  V C Bond; S Person; S C Warner
Journal:  J Gen Virol       Date:  1982-08       Impact factor: 3.891

7.  Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment.

Authors:  A Rösen; H Gelderblom; G Darai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

8.  Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion.

Authors:  A Baghian; L Huang; S Newman; S Jayachandra; K G Kousoulas
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K.

Authors:  H Ghiasi; S Slanina; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Pseudorabies virus and equine herpesvirus 1 share a nonessential gene which is absent in other herpesviruses and located adjacent to a highly conserved gene cluster.

Authors:  J Baumeister; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  5 in total

1.  Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument.

Authors:  E L Bearer; X O Breakefield; D Schuback; T S Reese; J H LaVail
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

3.  Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection.

Authors:  G L Demmin; A C Clase; J A Randall; L W Enquist; B W Banfield
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α.

Authors:  Sona Chowdhury; Misagh Naderi; Vladimir N Chouljenko; Jason D Walker; Konstantin G Kousoulas
Journal:  Virol J       Date:  2012-06-13       Impact factor: 4.099

5.  The herpes simplex virus 1 Us3 kinase is involved in assembly of membranes needed for viral envelopment and in distribution of glycoprotein K.

Authors:  Kurt Tobler; Claudia Senn; Elisabeth M Schraner; Mathias Ackermann; Cornel Fraefel; Peter Wild
Journal:  F1000Res       Date:  2019-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.